Risky business: The impact of antimicrobial prescribing on multidrug-resistant Gram-negative BSIs in acute myeloid leukemia patients.
Beatrice Z SimMonica A SlavinAbby P DouglasPublished in: Transplant infectious disease : an official journal of the Transplantation Society (2023)
Keyphrases
- multidrug resistant
- gram negative
- drug resistant
- end stage renal disease
- acinetobacter baumannii
- newly diagnosed
- ejection fraction
- primary care
- chronic kidney disease
- klebsiella pneumoniae
- staphylococcus aureus
- prognostic factors
- peritoneal dialysis
- patient reported outcomes
- escherichia coli
- patient reported
- cystic fibrosis
- adverse drug